These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15527404)

  • 1. Community pharmacy in Australia.
    Benrimoj SI; Frommer MS
    Aust Health Rev; 2004 Nov; 28(2):238-46. PubMed ID: 15527404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary health care policy and vision for community pharmacy and pharmacists in Australia.
    Dineen-Griffin S; Benrimoj SI; Garcia-Cardenas V
    Pharm Pract (Granada); 2020; 18(2):1967. PubMed ID: 32477437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consolidating innovative practice models: The case for obstructive sleep apnea services in Australian pharmacies.
    Hanes CA; Wong KK; Saini B
    Res Social Adm Pharm; 2015; 11(3):412-27. PubMed ID: 25262387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community pharmacy staff needs for the provision of oral health care education and advice in Australia.
    Taing MW; Ford PJ; Freeman C
    J Am Pharm Assoc (2003); 2020; 60(6):993-1000.e9. PubMed ID: 32863180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical care in community pharmacies: practice and research in the US.
    Christensen DB; Farris KB
    Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical care in community pharmacies: practice and research in Germany.
    Eickhoff C; Schulz M
    Ann Pharmacother; 2006 Apr; 40(4):729-35. PubMed ID: 16569798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New roles for community pharmacists in modern health care systems: a challenge for pharmacy education and research.
    Bugnon O; Hugentobler-Hampaï D; Berger J; Schneider MP
    Chimia (Aarau); 2012; 66(5):304-7. PubMed ID: 22867541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring oral healthcare management across Australian community pharmacies using case vignettes.
    Taing MW; Firth N; Ford PJ; Freeman CR
    Community Dent Oral Epidemiol; 2019 Jun; 47(3):225-235. PubMed ID: 30734359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom.
    Bush J; Langley CA; Wilson KA
    Res Social Adm Pharm; 2009 Dec; 5(4):305-18. PubMed ID: 19962674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apocalypse Now?
    Rupp MT
    Ann Pharmacother; 2017 Oct; 51(10):921-922. PubMed ID: 28608718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Social Pharmacy: Its Performance and Promise].
    Fukushima N
    Yakugaku Zasshi; 2016; 136(7):993-9. PubMed ID: 27374963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stakeholder analysis for the development of a community pharmacy service aimed at preventing cardiovascular disease.
    Franco-Trigo L; Hossain LN; Durks D; Fam D; Inglis SC; Benrimoj SI; Sabater-Hernández D
    Res Social Adm Pharm; 2017; 13(3):539-552. PubMed ID: 27485770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical care in community pharmacies: practice and research in Sweden.
    Westerlund LT; Björk HT
    Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards the implementation of breastfeeding-related health services in community pharmacies: Pharmacists' perspectives.
    Sim TF; Hattingh HL; Sherriff J; Tee LBG
    Res Social Adm Pharm; 2017; 13(5):980-988. PubMed ID: 28325528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacy practice in Japan--results of a survey.
    Iguchi S; Ohnishi M; Nishiyama T; Hosono K; Umezawa C
    J Clin Pharm Ther; 1998 Jun; 23(3):223-7. PubMed ID: 9831974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the Pharmacy Benefit Manager/Community Pharmacy Relationship: An Opportunity for Success.
    Taddei-Allen P
    J Manag Care Spec Pharm; 2020 Jun; 26(6):708-710. PubMed ID: 32463767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacy in Australia: a health hub destination of the future.
    McMillan SS; Wheeler AJ; Sav A; King MA; Whitty JA; Kendall E; Kelly F
    Res Social Adm Pharm; 2013; 9(6):863-75. PubMed ID: 23218552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist's Demand for Optimal Primary Care Service Delivery in a Community Pharmacy: The OPTiPharm Study.
    Munger MA; Walsh M; Godin J; Feehan M
    Ann Pharmacother; 2017 Dec; 51(12):1069-1076. PubMed ID: 28737045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.